Applying the illness-death model to estimate the incidence and remission of severe anxiety and depressive symptoms in the German National Cohort (NAKO)
Authors:
- Chisato ItoCIChisato Ito
- Bernhard T. BauneBBBernhard T. Baune
- Klaus BergerKBKlaus Berger
- [The German National Cohort (NAKO) Investigators][I[The German National Cohort (NAKO) Investigators]
- Tobias KurthTKTobias Kurth
- Ralph BrinksRBRalph Brinks
Open Access
- 29 January 2026
- journal article
- Published by Royal College of Psychiatrists in European Psychiatry
- Vol. 69 (1) , 1-33
Abstract
Background: Epidemiological evidence on the incidence and remission of anxiety and depressive disorders is limited. We estimated age- and sex-specific incidence and remission rates of moderate-to-severe anxiety and depressive symptoms using the illness-death model. Methods: The German National Cohort (NAKO) is a cohort of over 200,000 participants aged 19–74 at baseline. Prevalence of probable cases, estimated with the Generalized Anxiety Disorder Scale and the Patient Health Questionnaire data 2014–2019 across five regions, was related to general mortality rates and disorder-specific mortality rate ratios in the illness-death model. The partial derivative of prevalence was modeled as a function of incidence and remission, with parameters estimated via least-squares optimization through 2,000 bootstrap resamples. Results: The highest incidence rates (per 1,000 person-years) occurred at ages 19–21 for anxiety symptoms: 4.07 (95% CI: 0.00–7.57) in women and 2.55 (0.00–4.94) in men; and at ages 28–34 for depressive symptoms: 4.41 (0.00–9.81) in women and 3.30 (0.00–7.34) in men, all in Hamburg. Remission rates (per 100 person-years) were highest at older ages. For anxiety symptoms, rates peaked at 71.8 years in women (4.10 [0.00–11.94]) and 64.2 years in men (3.00 [0.00–9.23]) in Freiburg. For depressive symptoms, the highest observed was at 74.0 years, both among women (6.61 [0.00–15.50] in Münster) and men (3.58 [0.00–11.51] in Berlin). Conclusions: Incidence and remission rates of anxiety and depressive symptoms can be estimated from prevalence and mortality data, revealing regional, sex-, and age-related variation. Validation with longitudinal data is warranted.Keywords
This publication has 38 references indexed in Scilit:
- Age- and time-dependent model of the prevalence of non-communicable diseases and application to dementia in GermanyTheoretical Population Biology, 2014
- Two‐year course of anxiety disorders: different across disorders or dimensions?Acta Psychiatrica Scandinavica, 2012
- Deriving age‐specific incidence from prevalence with an ordinary differential equationStatistics in Medicine, 2012
- Cost of disorders of the brain in Europe 2010European Neuropsychopharmacology, 2011
- Prevalence, Comorbidity, and Service Utilization for Mood Disorders in the United States at the Beginning of the Twenty-first CenturyAnnual Review of Clinical Psychology, 2007
- A Brief Measure for Assessing Generalized Anxiety DisorderArchives of internal medicine (1960), 2006
- Influence of Psychiatric Comorbidity on Recovery and Recurrence in Generalized Anxiety Disorder, Social Phobia, and Panic Disorder: A 12-Year Prospective StudyAmerican Journal of Psychiatry, 2005
- Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS)Psychological Medicine, 2004
- The PHQ-9Journal of General Internal Medicine, 2001
- Statistical methods in cancer research. Volume I - The analysis of case-control studies.1980